Cytokinetics, Incorporated · NASDAQ:CYTK

Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)

Traded Apr 29, 2026 · Filed Apr 29, 2026

On Apr 29, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at US$59.62 for US$447K under a trading plan, leaving 407,830 shares. Filed Apr 29, 2026 (Form 4).

Sold
7,500 shares
Price
US$59.62
Value
US$447K
Holding after
407,830 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 29, 2026Common StockSale7,500US$59.62407,830Direct

Source

View original at SEC

Related